(Alliance News) - Rank Group PLC on Monday said its Spanish business, Enracha and Yo, has been the target of payment fraud, in new blow to the casino and bingo operator. Read More
(Alliance News) - The following London-listed shares received analyst recommendations since Friday morning: Read More
LondonMetric Property PLC - London-based real estate investment trust focuses on logistics, healthcare, convenience, entertainment and leisure properties - Sells two "mature" out-of-town retailing properties for GBP64.4 million and buys new warehouse properties for GBP26.2 million. Sells Cantium retail park in south east London occupied by B&Q, Pets at Home and other brands for GBP48.5 million, with LondonMetric's share of this GBP33.5 million. Also sells a retail property in Weymouth, England housing a Marks & Spencer store for GBP15.9 million. Buys two warehouses let to food wholesaler Booker. They are a logistics warehouse in Doncaster for GBP16.9 million and a Booker Cash & Carry in Southend-on-Sea for GBP9.3 million. B&Q is owned by Kingfisher PLC and Booker by Tesco PLC. Read More
(Alliance News) - Harbour Energy PLC on Monday said the USD3.2 billion acquisition of LLOG Exploration Co LLC will materially improve cash flow supporting "competitive shareholder distributions". Read More
Prudential PLC - London-based insurer focused on Asia and Africa - Completes share buyback worth GBP24.6 million that was launched to neutralise scrip dividend share issuance. Scrip dividends are paid in shares rather than cash as a tax efficiency option for shareholders. Prudential says 2.2 million shares were repurchased at an average price of 1,118.28 pence each in the programme, which began on Monday last week and was completed on Friday. Prudential's main share buyback, a GBP2 billion programme first announced in June 2024, continues. Read More
(Alliance News) - AstraZeneca PLC on Monday said a phase three trial in a potential treatment for a form of non-small cell lung cancer failed to meet a key aim, while its early breast cancer drug has been granted a breakthrough therapy designation in the US. Read More
(Alliance News) - European equities made a mixed start to the holiday-shortened week, but sterling perked up and gold achieved a new record high. Read More
Hiscox Ltd - Bermuda-based specialist insurer - Completes USD275 million share buyback on Friday. The buyback was started in February as a USD175 million programme and increased to USD275 million in August. Hiscox bought back 15.9 million shares in total. The buyback is run by Peel Hunt LLP and Citigroup Global Markets Ltd. Read More
IG Group Holdings PLC - London-based online trading platform - Says search for a new chair is "progressing well" but incumbent Mike McTighe has agreed to stay in the role until a successor is found. Back in September, IG had said McTighe would stay until the end of the year. He was appointed chair back in February 2020. Read More
(Alliance News) - Harbour Energy has struck a deal to deliver on a "long-standing ambition", while AstraZeneca reports a drug failed to meet its primary endpoint in a phase three trial, while another got breakthrough therapy designation in the US. Read More
(Alliance News) - The UK economy suffered a growth slowdown in the third quarter of the year, numbers from the Office for National Statistics confirmed on Monday. Read More
(Alliance News) - Stocks in London are set to open slightly lower at the start of a holiday-shortened week, before UK economic data, while gold powered to a new record level. Read More
(Alliance News) - Keir Starmer will "absolutely" be prime minister next Christmas, the chair of the Labour Party has said. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and Thursday and not separately reported by Alliance News: Read More
GSK PLC - London-based pharmaceuticals firm - Announces agreement with the US government to lower the cost of prescription medicines for American patients, including GSK's portfolio for respiratory conditions such as asthma and COPD. Says it will lower the price of certain medicines in Medicaid and "launch new products with a more balanced pricing approach", and will make most of its inhaled respiratory portfolio and other products available to patients on a direct purchasing platform with savings of up to 66%. Furthermore, it intends to further support the US supply chain for critical medicines by securing a reserve of albuterol, the active ingredient used in many inhalers to relieve the symptoms of asthma and COPD, for the US. Read More